Patients With Disparity for an HLA-A or -B Antigen
| UPN . | No. of CD4 Cells/kg (×10−4) . | No. of CD8 Cells/kg (×10−6) . | Graft Failure . | GVHD Grade . | Survival (d) . | Cause of Death . | |
|---|---|---|---|---|---|---|---|
| Given . | Intended . | ||||||
| 8351 | BL | 17.1 | NA | No | II | 54 | Recurrent malignancy |
| 8268 | 0.13 | 8.7 | NA | No | II | 180 | Chronic GVHD |
| 7911 | 21 | 8.7 | NA | No | III | 48 | Fungal infection |
| 7850 | 1.9 | 5.9 | 5.0 | No | II | >896 | |
| 9478 | BL | 5.4 | 5.0 | No | III | 817 | Unknown |
| 8945 | 0.59 | 4.7 | 5.0 | No | II | 42 | Fungal infection |
| 9994 | 0.13 | 4.6 | 5.0 | No | II | 243 | Recurrent malignancy |
| 8125 | 0.45 | 4.6 | NA | NE | NE | 12 | Fungal infection |
| 9542 | 0.30 | 4.1 | 5.0 | No | II | 648 | Chronic GVHD |
| 8553 | 0.046 | 3.9 | NA | No | III | 77 | Bacterial infection |
| 7872 | 0.61 | 3.1 | 2.5 | Yes | NE | 111 | Fungal infection |
| 8765 | 1.6 | 2.4 | 2.5 | No | II | 156 | Recurrent malignancy |
| 9022 | 1.9 | 2.2 | 2.5 | Yes* | IV | 67 | Bacterial infection |
| UPN . | No. of CD4 Cells/kg (×10−4) . | No. of CD8 Cells/kg (×10−6) . | Graft Failure . | GVHD Grade . | Survival (d) . | Cause of Death . | |
|---|---|---|---|---|---|---|---|
| Given . | Intended . | ||||||
| 8351 | BL | 17.1 | NA | No | II | 54 | Recurrent malignancy |
| 8268 | 0.13 | 8.7 | NA | No | II | 180 | Chronic GVHD |
| 7911 | 21 | 8.7 | NA | No | III | 48 | Fungal infection |
| 7850 | 1.9 | 5.9 | 5.0 | No | II | >896 | |
| 9478 | BL | 5.4 | 5.0 | No | III | 817 | Unknown |
| 8945 | 0.59 | 4.7 | 5.0 | No | II | 42 | Fungal infection |
| 9994 | 0.13 | 4.6 | 5.0 | No | II | 243 | Recurrent malignancy |
| 8125 | 0.45 | 4.6 | NA | NE | NE | 12 | Fungal infection |
| 9542 | 0.30 | 4.1 | 5.0 | No | II | 648 | Chronic GVHD |
| 8553 | 0.046 | 3.9 | NA | No | III | 77 | Bacterial infection |
| 7872 | 0.61 | 3.1 | 2.5 | Yes | NE | 111 | Fungal infection |
| 8765 | 1.6 | 2.4 | 2.5 | No | II | 156 | Recurrent malignancy |
| 9022 | 1.9 | 2.2 | 2.5 | Yes* | IV | 67 | Bacterial infection |
Patients are listed according to the number of CD8 cells in the graft.
Abbreviations: UPN, unique patient number; BL, below limits of detection; NA, not applicable because CD8 cells were not removed from the marrow for these patients; NE, not evaluable for graft failure because of early death, or not evaluable for acute GVHD because donor cells did not engraft.
This patient had graft failure after initial engraftment.